All News

FDA plans to finalize the draft in 2019. 

How targeted therapy could be the pathway to improved cancer treatment.

Fourth indication for the drug since 2014.

Biotech companies join forces to develop oral flu vaccines.

Lack of trust in vaccines abetted by online articles and past wrongdoing by the drug industry.

"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan

Update: Recall expanded to Natural Ophthalmics and TRP Company, Inc. 

Some jobs may disappear while others evolve and require further training.

Combination drug indicated for infections caused by susceptible gram-negative bacteria.

Fourth approval for use in assessing myocardial perfusion and late gadolinium enhancement.

COMT inhibitor to be used as an adjunctive treatment to levodopa/carbidopa.

New study examines effective implementation of team-based care in community pharmacies. 

Changes fueled by the 2003 Medicare Prescription Drug Improvement and Modernization Act.

CBD market will grow by over 700% in 2019.

25 murder charges against one physician leads to multiple firings at Ohio hospital.

Comprehensive medication management may lower costs and improve lives. 

Rule would cost $177 billion through 2029.

Exciting and upcoming developments, years in the making.

Results from new ASHP Survey.

By 2020, industry experts believe specialty drugs will account for 50% of U.S. spending on pharmaceuticals.

Pharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.

Shingles is associated with a statistically significant increase in the risk of myocardial infarction, stroke, and transient ischemic attack.

3% of nationwide pharmacy staff laid of nationwide; nearly half were senior pharmacists.

At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.

Value-based programs emphasize better care, enhanced health, and lower costs.